XML 50 R39.htm IDEA: XBRL DOCUMENT v3.19.1
Research and License Agreements - Additional Information (Details)
1 Months Ended 3 Months Ended 12 Months Ended
Jun. 30, 2015
USD ($)
May 31, 2014
USD ($)
Mar. 31, 2019
USD ($)
item
Mar. 31, 2018
USD ($)
Dec. 31, 2011
USD ($)
item
Research and License Agreements          
Non-refundable milestone payment received $ 20,000,000 $ 15,000,000      
Revenue      
Number of milestones included in transaction price | item     0    
License Agreement | Pfizer          
Research and License Agreements          
Up-front payment received         $ 22,500,000
Revenue     $ 0 0  
Transaction price         22,500,000
Research Services Agreement | University Of Basel          
Research and License Agreements          
Milestone payment obligation     $ 0 $ 0  
Royalty payment due against license fees received (as a percent)     10.00%    
Achievement Of Specified Development Milestone | License Agreement | Pfizer | Maximum          
Research and License Agreements          
Potential milestone payments         $ 115,000,000
Number of indications | item         2
Achievement Of Specified Regulatory Milestone | License Agreement | Pfizer | Maximum          
Research and License Agreements          
Potential milestone payments         $ 70,000,000
Number of indications | item         2
Achievement Of Specified Levels Of Annual Net Sales Of Licensed Products | License Agreement | Pfizer | Maximum          
Research and License Agreements          
Potential milestone payments         $ 135,000,000